A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BRENIPATIDE IN THE TREATMENT OF ADULT PARTICIPANTS WITH IBS-D

Registry ID

J2S-MC-GZMS

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

ELI LILLY CANADA INC

Start date

2026-06-15

Last update

2026-04-17

Conditions

• IRRITABLE BOWEL SYNDROME

Related clinical trials

• A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BRENIPATIDE IN THE TREATMENT OF ADULT PARTICIPANTS WITH IBS-C
• A PHASE 2, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND INDUCTION STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL TAK-279 IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
• A PHASE 3, OPEN-LABEL, LONG-TERM SAFETY STUDY OF ORAL LINACLOTIDE ADMINISTERED TO PEDIATRIC PARTICIPANTS WITH FUNCTIONAL CONSTIPATION (FC) OR IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C)

View on source registry